Mounier, Ninon
Voller, Bethany https://orcid.org/0009-0006-7189-1375
Masoli, Jane A. H.
Delgado, João
Dudbridge, Frank https://orcid.org/0000-0002-8817-8908
Pilling, Luke C. https://orcid.org/0000-0002-3332-8454
Frayling, Timothy M.
Bowden, Jack https://orcid.org/0000-0003-2628-3304
,
Masoli, Jane AH
Murrin, Olivia
Tata, Linus
Gallego-Moll, Carlos
Roso-Llorach, Albert
Carrasco-Ribelles, Lucía A.
Fox, Chris
Allan, Louise M.
Woodward, Ruby M.
Liang, Xiaoran
Valderas, Jose M.
Khalid, Sara M.
Lamb, Sally E.
Mancini, Mary
Farmer, Leon
Boddy, Kate
Melzer, David
Violán, Concepción
Funding for this research was provided by:
DH | NIHR | Health Technology Assessment Programme
Article History
Received: 22 July 2024
Accepted: 18 December 2025
First Online: 4 February 2026
Competing interests
: J.B. is a part-time employee of Novo Nordisk Research Centre Oxford, limited. T.F. has consulted for several pharmaceutical companies. All other authors have no disclosures to declare.